Detalhe da pesquisa
1.
Budesonide/formoterol via Turbuhaler® versus formoterol via Turbuhaler® in patients with moderate to severe chronic obstructive pulmonary disease: phase III multinational study results.
Respirology
; 18(5): 866-73, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23551359
2.
Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: phase III study results.
Respirology
; 18(2): 354-63, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23126237
3.
Risks of pneumonia in patients with asthma taking inhaled corticosteroids.
Am J Respir Crit Care Med
; 183(5): 589-95, 2011 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20889908
4.
Pharmacokinetic and pharmacodynamic comparison of hydrofluoroalkane and chlorofluorocarbon formulations of budesonide.
Br J Clin Pharmacol
; 71(4): 504-13, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21395643
5.
Budesonide inhalation suspension versus montelukast in children aged 2 to 4 years with mild persistent asthma.
J Allergy Clin Immunol Pract
; 1(1): 58-64, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24229823
6.
The poorly explored impact of uncontrolled asthma.
Chest
; 143(2): 511-523, 2013 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23381316
7.
Onset of action of formoterol versus salmeterol via dry powder inhalers in moderate chronic obstructive pulmonary disease: a randomized, placebo-controlled, double-blind, crossover study.
Clin Drug Investig
; 32(3): 147-55, 2012 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22235841
8.
Evaluation of efficacy and safety of budesonide delivered via two dry powder inhalers.
Curr Med Res Opin
; 24(5): 1497-510, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18419878